The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review

BMC Psychiatry

Gustav J Dobos¹  Florian Gass¹  Romy Lauche¹  Holger Cramer¹  Heidemarie Haller¹ 

[1] Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University Duisburg-Essen, Am Deimelsberg 34a, 45276 Essen, Germany

关键词: Systematic review;    Burden of illness;    Epidemiology;    Anxiety disorders;   

Others  :  1123610
DOI  :  10.1186/1471-244X-14-128

 received in 2013-07-04, accepted in 2014-04-23,  发布年份 2014

【 摘 要 】

Background

To review the prevalence and impact of generalized anxiety disorder (GAD) below the diagnostic threshold and explore its treatment needs in times of scarce healthcare resources.

Methods

A systematic literature search was conducted until January 2013 using PUBMED/MEDLINE, PSYCINFO, EMBASE and reference lists to identify epidemiological studies of subthreshold GAD, i.e. GAD symptoms that do not reach the current thresholds of DSM-III-R, DSM-IV or ICD-10. Quality of all included studies was assessed and median prevalences of subthreshold GAD were calculated for different subpopulations.

Results

Inclusion criteria led to 15 high-quality and 3 low-quality epidemiological studies with a total of 48,214 participants being reviewed. Whilst GAD proved to be a common mental health disorder, the prevalence for subthreshold GAD was twice that for the full syndrome. Subthreshold GAD is typically persistent, causing considerably more suffering and impairment in psychosocial and work functioning, benzodiazepine and primary health care use, than in non-anxious individuals. Subthreshold GAD can also increase the risk of onset and worsen the course of a range of comorbid mental health, pain and somatic disorders; further increasing costs. Results are robust against bias due to low study quality.

Conclusions

Subthreshold GAD is a common, recurrent and impairing disease with verifiable morbidity that claims significant healthcare resources. As such, it should receive additional research and clinical attention.

【 授权许可】

   
2014 Haller et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU: Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 2001, 62(Suppl. 11):53-58.
• [2]Kessler RC, Wittchen HU: Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry 2002, 63(Suppl. 8):4-10.
• [3]Wittchen HU, Hoyer J: Generalized anxiety disorder: nature and course. J Clin Psychiatry 2001, 62(Suppl. 11):15-21.
• [4]American Psychiatric Association: Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Publishing; 2000.
• [5]World Health Organization: International statistical classification of diseases and health related problems, tenth revision (ICD-10). Geneva: World Health Organization; 2004.
• [6]Barlow DH, Campbell LA: Mixed anxiety-depression and its implications for models of mood and anxiety disorders. Compr Psychiatry 2000, 41(2 Suppl. 1):55-60.
• [7]Beekman AT, Deeg DJ, Braam AW, Smit JH, Van Tilburg W: Consequences of major and minor depression in later life: a study of disability, well-being and service utilization. Psychol Med 1997, 27(6):1397-1409.
• [8]Maier W, Gansicke M, Weiffenbach O: The relationship between major and subthreshold variants of unipolar depression. J Affect Disord 1997, 45(1–2):41-51.
• [9]Mendlowicz MV, Stein MB: Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000, 157(5):669-682.
• [10]Okasha A: Would the use of dimensions instead of categories remove problems related to subthreshold disorders? Eur Arch Psychiatry Clin Neurosci 2009, 259(Suppl. 2):S129-133.
• [11]Druss BG, Wang PS, Sampson NA, Olfson M, Pincus HA, Wells KB, Kessler RC: Understanding mental health treatment in persons without mental diagnoses: results from the national comorbidity survey replication. Arch Gen Psychiatry 2007, 64(10):1196-1203.
• [12]Bystritsky A, Kerwin L, Niv N, Natoli JL, Abrahami N, Klap R, Wells K, Young AS: Clinical and subthreshold panic disorder. Depress Anxiety 2010, 27(4):381-389.
• [13]Cuijpers P, Smit F: Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand 2004, 109(5):325-331.
• [14]Goodwin RD, Faravelli C, Rosi S, Cosci F, Truglia E, de Graaf R, Wittchen HU: The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol 2005, 15(4):435-443.
• [15]Grenier S, Schuurmans J, Goldfarb M, Preville M, Boyer R, O’Connor K, Potvin O, Hudon C: Scientific committee of the ESAs: the epidemiology of specific phobia and subthreshold fear subtypes in a community-based sample of older adults. Depress Anxiety 2011, 28(6):456-463.
• [16]Knappe S, Beesdo K, Fehm L, Lieb R, Wittchen HU: Associations of familial risk factors with social fears and social phobia: evidence for the continuum hypothesis in social anxiety disorder? J Neural Transm 2009, 116(6):639-648.
• [17]Meeks TW, Vahia IV, Lavretsky H, Kulkarni G, Jeste DV: A tune in “a minor” can “b major”: a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. J Affect Disord 2011, 129(1–3):126-142.
• [18]Skapinakis P, Lewis G, Davies S, Brugha T, Prince M, Singleton N: Panic disorder and subthreshold panic in the UK general population: epidemiology, comorbidity and functional limitation. Eur Psychiatry 2011, 26(6):354-362.
• [19]Volz HP, Gastpar M, Kasper S: Subsyndromale angststörungen: definition, messparameter. Epidemiologie J Neurol Neurochir Psychiatr 2011, 12(2):162-167.
• [20]Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
• [21]Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW: Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 1998, 19(4):170-176.
• [22]Angst J: Depression and anxiety: implications for nosology, course, and treatment. J Clin Psychiatry 1997, 58(Suppl. 8):3-5.
• [23]Angst J, Gamma A, Clarke D, Ajdacic-Gross V, Rossler W, Regier D: Subjective distress predicts treatment seeking for depression, bipolar, anxiety, panic, neurasthenia and insomnia severity spectra. Acta Psychiatr Scand 2010, 122(6):488-498.
• [24]Angst J, Gamma A, Baldwin DS, Ajdacic-Gross V, Rossler W: The generalized anxiety spectrum: prevalence, onset, course and outcome. Eur Arch Psychiatry Clin Neurosci 2009, 259(1):37-45.
• [25]Ansseau M, Dierick M, Buntinkx F, Cnockaert P, De Smedt J, Van Den Haute M, Vander Mijnsbrugge D: High prevalence of mental disorders in primary care. J Affect Disord 2004, 78(1):49-55.
• [26]Berardi D, Berti Ceroni G, Leggieri G, Rucci P, Ustun B, Ferrari G: Mental, physical and functional status in primary care attenders. Int J Psychiatry Med 1999, 29(2):133-148.
• [27]Creed F, Morgan R, Fiddler M, Marshall S, Guthrie E, House A: Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 2002, 43(4):302-309.
• [28]de Beurs E, Beekman AT, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W: Consequences of anxiety in older persons: its effect on disability, well-being and use of health services. Psychol Med 1999, 29(3):583-593.
• [29]Gallerani CM, Garber J, Martin NC: The temporal relation between depression and comorbid psychopathology in adolescents at varied risk for depression. J Child Psychol Psychiatry 2010, 51(3):242-249.
• [30]Jackson JL, Passamonti M, Kroenke K: Outcome and impact of mental disorders in primary care at 5 years. Psychosom Med 2007, 69(3):270-276.
• [31]Karsten J, Penninx BW, Verboom CE, Nolen WA, Hartman CA: Course and risk factors of functional impairment in subthreshold depression and anxiety. Depress Anxiety 2012, 30(4):386-394.
• [32]Kvaal K, McDougall FA, Brayne C, Matthews FE, Dewey ME, CFAS M: Co-occurrence of anxiety and depressive disorders in a community sample of older people: results from the MRC CFAS (medical research council cognitive function and ageing study). Int J Geriatr Psychiatry 2008, 23(3):229-237.
• [33]Lewinsohn PM, Shankman SA, Gau JM, Klein DN: The prevalence and co-morbidity of subthreshold psychiatric conditions. Psychol Med 2004, 34(4):613-622.
• [34]Pini S, Perkonnig A, Tansella M, Wittchen HU, Psich D: Prevalence and 12-month outcome of threshold and subthreshold mental disorders in primary care. J Affect Disord 1999, 56(1):37-48.
• [35]Roy-Byrne P, Katon W, Broadhead WE, Lepine JP, Richards J, Brantley PJ, Russo J, Zinbarg R, Barlow D, Liebowitz M: Subsyndromal (“mixed”) anxiety - depression in primary care. J Gen Intern Med 1994, 9(9):507-512.
• [36]Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU: Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 1996, 30:38-43.
• [37]Shankman SA, Klein DN, Lewinsohn PM, Seeley JR, Small JW: Family study of subthreshold psychopathology in a community sample. Psychol Med 2008, 38(2):187-198.
• [38]Shankman SA, Lewinsohn PM, Klein DN, Small JW, Seeley JR, Altman SE: Subthreshold conditions as precursors for full syndrome disorders: a 15-year longitudinal study of multiple diagnostic classes. J Child Psychol Psychiatry 2009, 50(12):1485-1494.
• [39]Simon G, Ormel J, VonKorff M, Barlow W: Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995, 152(3):352-357.
• [40]Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FV 3rd, Brody D, Davies M: Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA 1995, 274(19):1511-1517.
• [41]Tiwari SK, Wang J: The epidemiology of mental and substance use-related disorders among white, Chinese, and other Asian populations in Canada. Can J Psychiatry 2006, 51(14):904-912.
• [42]Wittchen HU, Nelson CB, Lachner G: Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 1998, 28(1):109-126.
• [43]Angst J, Gamma A, Bienvenu OJ, Eaton WW, Ajdacic V, Eich D, Rossler W: Varying temporal criteria for generalized anxiety disorder: prevalence and clinical characteristics in a young age cohort. Psychol Med 2006, 36(9):1283-1292.
• [44]Beesdo K, Hoyer J, Jacobi F, Low NC, Hofler M, Wittchen HU: Association between generalized anxiety levels and pain in a community sample: evidence for diagnostic specificity. J Anxiety Disord 2009, 23(5):684-693.
• [45]Bienvenu OJ, Nestadt G, Eaton WW: Characterizing generalized anxiety: temporal and symptomatic thresholds. J Nerv Ment Dis 1998, 186(1):51-56.
• [46]Carter RM, Wittchen HU, Pfister H, Kessler RC: One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 2001, 13(2):78-88.
• [47]Grenier S, Preville M, Boyer R, O’Connor K, Beland SG, Potvin O, Hudon C, Brassard J: Scientific Committee of the ESAS: the impact of DSM-IV symptom and clinical significance criteria on the prevalence estimates of subthreshold and threshold anxiety in the older adult population. Am J Geriatr Psychiatry 2011, 19(4):316-326.
• [48]Heun R, Papassotiropoulos A, Ptok U: Subthreshold depressive and anxiety disorders in the elderly. Eur Psychiatry 2000, 15(3):173-182.
• [49]Hoyer J, Becker ES, Margraf J: Generalized anxiety disorder and clinical worry episodes in young women. Psychol Med 2002, 32(7):1227-1237.
• [50]Kertz SJ, Woodruff-Borden J: Human and economic burden of GAD, subthreshold GAD, and worry in a primary care sample. J Clin Psychol Med Settings 2011, 18(3):281-290.
• [51]Kessler RC, Brandenburg N, Lane M, Roy-Byrne P, Stang PD, Stein DJ, Wittchen HU: Rethinking the duration requirement for generalized anxiety disorder: evidence from the national comorbidity survey replication. Psychol Med 2005, 35(7):1073-1082.
• [52]Maier W, Gansicke M, Freyberger HJ, Linz M, Heun R, Lecrubier Y: Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatr Scand 2000, 101(1):29-36.
• [53]Olfson M, Broadhead WE, Weissman MM, Leon AC, Farber L, Hoven C, Kathol R: Subthreshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry 1996, 53(10):880-886.
• [54]Potvin O, Hudon C, Dion M, Grenier S, Preville M: Anxiety disorders, depressive episodes and cognitive impairment no dementia in community-dwelling older men and women. Int J Geriatr Psychiatry 2011, 26(10):1080-1088.
• [55]Rucci P, Gherardi S, Tansella M, Piccinelli M, Berardi D, Bisoffi G, Corsino MA, Pini S: Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. J Affect Disord 2003, 76(1–3):171-181.
• [56]Ruscio AM, Chiu WT, Roy-Byrne P, Stang PE, Stein DJ, Wittchen HU, Kessler RC: Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the national comorbidity survey replication. J Anxiety Disord 2007, 21(5):662-676.
• [57]Szádóczky E, Rózsa S, Zámbori J, Füredi J: Anxiety and mood disorders in primary care practice. Int J Psychiatry Clin Pract 2004, 8(2):77-84.
• [58]Weiller E, Bisserbe JC, Maier W, Lecrubier Y: Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on psychological problems in general health care. Br J Psychiatry Suppl 1998, 34:18-23.
• [59]Wetherell JL, Le Roux H, Gatz M: DSM-IV criteria for generalized anxiety disorder in older adults: distinguishing the worried from the well. Psychol Aging 2003, 18(3):622-627.
• [60]Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J: Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002, 63(Suppl. 8):24-34.
• [61]Angst J, Dobler-Mikola A, Binder J: The Zurich study - a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. Eur Arch Psychiatry Neurol Sci 1984, 234(1):13-20.
• [62]Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE: Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996, 19(10):1097-1102.
• [63]Heun R, Hardt J, Muller H, Maier W: Selection bias during recruitment of elderly subjects from the general population for psychiatric interviews. Eur Arch Psychiatry Clin Neurosci 1997, 247(2):87-92.
• [64]Jacobi F, Wittchen HU, Holting C, Sommer S, Lieb R, Hofler M, Pfister H: Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German national health interview and examination survey. Int J Methods Psychiatr Res 2002, 11(1):1-18.
• [65]Kessler RC, Berglund P, Chiu WT, Demler O, Heeringa S, Hiripi E, Jin R, Pennell BE, Walters EE, Zaslavsky A, Zheng H: The US national comorbidity survey replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res 2004, 13(2):69-92.
• [66]Sartorius N, Ustun TB, Costa e Silva JA, Goldberg D, Lecrubier Y, Ormel J, Von Korff M, Wittchen HU: An international study of psychological problems in primary care. Preliminary report from the world health organization collaborative project on ‘psychological problems in general health care’. Arch Gen Psychiatry 1993, 50(10):819-824.
• [67]Cuijpers P, Smit F, van Straten A: Psychological treatments of subthreshold depression: a meta-analytic review. Acta Psychiatr Scand 2007, 115(6):434-441.
• [68]Meulenbeek P, Willemse G, Smit F, van Balkom A, Spinhoven P, Cuijpers P: Early intervention in panic: pragmatic randomised controlled trial. Br J Psychiatry 2010, 196(4):326-331.
• [69]Kasper S, Gastpar M, Muller WE, Volz HP, Moller HJ, Dienel A, Schlafke S: Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol 2010, 25(5):277-287.
• [70]van’t Veer-Tazelaar P, Smit F, van Hout H, van Oppen P, van der Horst H, Beekman A, van Marwijk H: Cost-effectiveness of a stepped care intervention to prevent depression and anxiety in late life: randomised trial. Br J Psychiatry 2010, 196(4):319-325.
• [71]van’t Veer-Tazelaar PJ, van Marwijk HWJ, van Oppen P, van der Horst HE, Smit F, Cuijpers P, Beekman ATF: Prevention of late-life anxiety and depression has sustained effects over 24 months. Am J Geriatr Psychiatry 2011, 19(3):230-239.
• [72]Coyne JC, Schwenk TL, Fechner-Bates S: Nondetection of depression by primary care physicians reconsidered. Gen Hosp Psychiatry 1995, 17(1):3-12.
• [73]Helmchen H, Linden M: Subthreshold disorders in psychiatry: clinical reality, methodological artifact, and the double-threshold problem. Compr Psychiatry 2000, 41(2 Suppl. 1):1-7.
• [74]Starcevic V, Portman ME, Beck AT: Generalized anxiety disorder: between neglect and an epidemic. J Nerv Ment Dis 2012, 200(8):664-667.
• [75]American Psychiatric Association: Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Arlington: American Psychiatric Publishing; 2013.
• [76]Hall RC: Global assessment of functioning. A modified scale. Psychosomatics 1995, 36(3):267-275.